| May 9, 2023 (view filing) | May 5-8 | 4 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −3.27K | $350.00 | −$1.15M | −9.3%32.0K after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| May 4, 2023 (view filing) | May 2-3 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −4.40K | $350.71 | −$1.54M | −11.1%35.3K after | 5 lotsThis row combines 5 trades of the same kind from one filing. The price is the value-weighted average.10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| Apr 14, 2023 (view filing) | Apr 12 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −7.57K | $326.70 | −$2.47M | −16.0%39.7K after | 3 lotsThis row combines 3 trades of the same kind from one filing. The price is the value-weighted average.10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −522 | $315.81 | −$164.9K | −1.1%47.3K after | 5 lotsThis row combines 5 trades of the same kind from one filing. The price is the value-weighted average.10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −2.75K | $300.59 | −$825.4K | −5.3%49.3K after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average.10b5-1The filer checked the Rule 10b5-1 box: this trade was made under a trading plan set up in advance. |
| Feb 16, 2023 (view filing) | Feb 14 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −2.18K | $300.39 | −$655.2K | −3.5%59.7K after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
| Feb 14, 2023 (view filing) | Feb 13 | 1 day | Sanna BastianoEVP, Cell & Genetic Therapies | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −113 | $300.39 | −$33.9K | −0.2%61.9K after | |
| Feb 2, 2023 (view filing) | Jan 31 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −106 | $325.00 | −$34.5K | −0.3%38.0K after | |
| Nov 3, 2022 (view filing) | Nov 2 | 1 day | Sanna BastianoEVP, Cell & Genetic Therapies | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −320 | $312.64 | −$100.0K | −0.8%38.1K after | 7 lotsThis row combines 7 trades of the same kind from one filing. The price is the value-weighted average. |
| Oct 20, 2022 (view filing) | Oct 18 | 2 days | Sanna BastianoEVP, Cell & Genetic Therapies | SSaleThe insider sold shares on the open market or in a private deal. People sell for many reasons, such as paying taxes, diversifying or following a pre-set 10b5-1 plan, so a single sale usually says less than a purchase. | −1.79K | $300.31 | −$537.9K | −4.4%39.2K after | 2 lotsThis row combines 2 trades of the same kind from one filing. The price is the value-weighted average. |
